Latest news
Loading news…
ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic viruses.
Vira Therapeutics was acquired by Boehringer Ingelheim in 2018 for $245M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Innsbruck, Tirol, Austria
Key People at Vira Therapeutics
Co-Founder & CEO
1
professional contacts at Vira Therapeutics
Contact execs at Vira Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vira Therapeutics
Loading news…
FAQs about Vira Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.